Bakery Proteases Market

How big is Bakery Proteases Market in 2026?

USD 213.0 million in 2026 and USD 455.6 million by 2036 at a 7.9% CAGR.

Bakery protease demand is projected to expand at 7.9% CAGR from 2026 to 2036 as industrial bakery enzymes are specified against flour strength and line speed. USDA NASS measured second-quarter 2025 flour production at 103 million hundredweight in its August release. That volume makes small reductions in rest time or machining variability commercially meaningful over repeated flour runs.

Country conversion rates differ with bakery structure and technical qualification cost, which changes how quickly a validated enzyme becomes a recurring specification. Defra statistics published in July 2026 counted about 24,880 UK food-and-drink manufacturing SMEs and put SMEs at 98.8% of sector businesses. That fragmented manufacturing base increases the value of distributor training and local application support, while Gulf expansion places more weight on regional inventory and faster plant trials.

Key Takeaways

• Demand rises as industrial bakers use controlled gluten relaxation to reduce rest time and stabilize dough handling between changing flour lots.
• By product type, standard grade is estimated to hold 45.0% in 2026 owing to routine processing programs that prioritize established activity specifications.
• In 2026, powder - dry is expected to lead form with 43.0% share because dry premixes fit existing flour-side dosing and distributor workflows.
• Bread & rolls are projected to hold 34.0% share in 2026 owing to frequent rheology adjustment on high-throughput dough lines.
• Qualification slows when a narrow dose window or regulatory status requires repeated plant trials before a bakery can standardize the new enzyme input.
• Some of the key players in this market include Novonesis, IFF, Kerry Group, AB Enzymes, Puratos, Corbion, dsm-firmenich, and Lallemand.

Analyst Perspective

“Bakery proteases earn their place only after a plant proves the usable dose window against its actual flour and line speed. Commercial value comes from reducing rest time or machining variability without weakening loaf structure or forcing repeated recipe qualification.”

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How is the bakery proteases market segmented?

The market is analyzed by product type, form, application, claim, sales channel and region.

Product type covers standard grade, premium / specialty grade, organic certified and clean label grade. Form includes powder - dry, liquid, paste / semi-solid and granules / pieces. Application spans bread & rolls, cakes & muffins, biscuits & cookies, viennoiserie & pastry and other bakery & snacks. Claim includes conventional, clean label, organic and non-GMO / identity preserved. Sales channel covers direct to industrial bakeries, ingredient distributors, foodservice & artisan supply and online B2B.

What makes Standard grade central to the Product Type category?

Standard grade fits protease demand because plant technologists usually solve a defined rheology problem before considering claim-specific certification and a flour-specific dose window.

• Based on product type, standard grade is projected to account for 45.0% in 2026 due to broad process fit in conventional bakery formulations.
• Qualification still turns on documented use conditions after a plant identifies the required dough effect. FDA closed AB Enzymes GRN 1197 in March 2025 with no questions for fructanase use up to 12 mg TOS/kg in baking, demonstrating how regulators review dosage conditions.

Why does Powder - dry lead the Form category?

Powder - dry formats fit premix operations that meter flour conditioners and bread improvers through existing dry systems. FDA closed AB Enzymes GRN 1196 in March 2025 with no questions for lipase use up to 4 mg TOS/kg flour in baked goods, defining documented dosage conditions.

• By form, powder - dry is forecast to represent 43.0% in 2026 driven by dry premix workflows and flour-side dosing routines.
• Dry premixes distribute low-dose enzyme activity with other flour conditioners before the blend reaches a bakery line, reducing separate additions during routine production.

How do Bread & rolls anchor the Application category?

Bread lines expose dough to mixing and forming steps where rheology errors are expensive, so protease selection belongs with dough improvers in one operating decision.

• Bread & rolls are set to lead the application category with 34.0% share in 2026 due to frequent rheology adjustment on high-throughput dough lines.
• Bread plants qualify enzyme systems against measurable product results before extending use to multiple SKUs. IFF launched POWERFRESH ACE 2000 in August 2025 for USA industrial bakeries and reported softness and resilience for up to 34 days, confirming performance-based enzyme qualification.

What drives Direct to industrial bakeries in the Sales Channel category?

Direct sales begin with flour-specific trials because protease response changes materially with flour strength and mixer conditions. FDA closed AB Enzymes GRN 1276 in April 2026 with no questions for cellulase use up to 19 mg TOS/kg in baked goods, showing why food enzymes need documented conditions.

• Direct to industrial bakeries is likely to capture 50.0% share in 2026 attributable to plant-specific qualification and application trials.
• Direct technical teams adjust enzyme dose against flour strength and mixer conditions before purchasing, making distributor replenishment easier after the plant fixes that operating window.

What are the drivers, restraints and opportunities in the Bakery Proteases Market?

Demand is supported by flour-standardization and dough-relaxation needs. Dose sensitivity and regulatory qualification restrain switching, while claim-led and cost-focused reformulation expands the value of application support.

• Driver: Industrial bread lines justify protease use once shorter rest time or steadier machining offsets the cost of qualification and flour variability.
• Restraint: An unsuitable protease dose can weaken gluten beyond the production target and extend plant trials before a recipe change is approved.
• Opportunity: Reformulation programs reward enzyme companies that preserve dough handling while bakeries reduce conventional conditioners or adapt to changing flour quality.

Large flour throughput makes small dough-handling gains visible in the operating economics of industrial bakeries that run high daily volumes. USDA ERS estimated USA wheat flour use at 126.6 pounds per person in 2025, indicating the scale of recurring flour processing. Industrial bakers can recover qualification costs after enzyme platforms prove a dose that shortens rest time or steadies machining under normal flour-lot changes.

Protease qualification slows because an unsuitable dose can weaken gluten beyond the current production target. UK government guidance updated in July 2026 kept food enzymes within the domestic authorization transition under assimilated Regulation 1332/2008, so plants must maintain current status records beside trial evidence. Technical teams also need proof that rheology gains survive normal line conditions without changing finished-product structure.

Reformulation work gives protease specialists a higher-value route when bakers reduce conventional conditioners without losing dough stability. Clean-label bakery programs therefore depend on application evidence under the customer’s flour and process conditions. dsm-firmenich opened its Princeton Baking Innovation Center in May 2025 and included enzymes among the bakery tools available for customer trials. Comparable programs favor protease companies that prove stable dose windows before commercial scale-up and routine specification.

Which country CAGRs are profiled in the Bakery Proteases Market?

Country	CAGR
UAE	9.3%
Saudi Arabia	9.0%
South Korea	8.7%
UK	8.4%
USA	8.1%

How do country-level CAGRs compare in the Bakery Proteases Market?

The profiles span 1.2 percentage points from UAE at 9.3% to USA at 8.1% during 202602036. UAE and Saudi Arabia form the highest-growth pair, while South Korea separates them from the UK-USA band. The narrow range changes sales sequencing but keeps qualification economics central to country prioritization.

• UAE qualification cycles reward technical response once bread plants move from trial batches into routine production.
• Saudi Arabia favors regional service models that extend technical coverage without duplicating a full application laboratory locally.
• South Korean bakery programs reward small-lot trials before differentiated formulations move into national production schedules.
• UK private-label bakeries weigh reformulation economics against line downtime and traceability during each enzyme supplier review.
• USA bakery groups favor standardized technical dossiers that multiple plant teams can review during specification changes.

Commercial priority also depends on account concentration and qualification cost because the report's regional taxonomy provides wider country-level CAGR analysis.

Country-wise Analysis

• UAE domestic bread plants are qualifying more local inputs as policy directs essential foods toward national production, increasing the value of application teams that can respond quickly during commissioning and first commercial trials. Bakery protease demand in UAE is projected to grow at 9.3% CAGR during 2026-2036 owing to expansion in bread and flour manufacturing, though new entrants must prove stable dough response under local flour conditions before a recipe is standardized. In April 2026 the UAE Cabinet placed bread and flour in the first phase of its national-product program covering critical goods, making documented supply continuity a practical entry requirement for enzyme companies serving new capacity.
• Ahead of pilgrimage demand peaks, Saudi industrial bakeries need enzyme changes to fit audited production controls without interrupting high-volume operating windows or existing food-safety procedures. The Saudi Food and Drug Authority documented more than 300 food-factory inspections in Makkah and Al Madinah before Hajj during May 2025, which raises the value of complete specifications and disciplined enzyme-handling records during qualification. Bakery protease demand in Saudi Arabia is forecast to advance at 9.0% CAGR through 2036 influenced by local manufacturing growth, although inconsistent technical support can exclude enzyme companies from programs that require repeatable dough performance during seasonal volume surges.
• South Korean bakery processors work inside a detailed additive code while short product cycles increase the value of local teams that can translate global enzyme dossiers into approved specifications. Bakery protease demand in South Korea is estimated to rise at 8.7% CAGR through 2036 given the need for predictable dough handling in tightly controlled formulations, but documentation review can delay a technically suitable product. In March 2025 the Ministry of Food and Drug Safety incorporated Notice 2025-15 into its Food Additives Code and published a 638-item additive list, favoring companies that maintain current Korean regulatory records and local review support.
• Regulatory change is not the only qualification cost for UK bakery enzyme programs, because industrial plants also need evidence that a new dose survives normal flour and line variation. Office for National Statistics data published in November 2025 recorded a 3.3% growth reading for bakery and farinaceous products in September, confirming active production conditions without proving enzyme uptake or a purchase decision. Bakery protease demand in the UK is projected to record 8.4% CAGR during 2026-2036 supported by reformulation work, yet fragmented smaller manufacturers and changing authorization requirements keep distributor training plus traceability and plant evidence inside each specification decision.
• At multi-site USA bread companies, production teams usually demand plant-scale evidence before replacing a current dough conditioner on several high-throughput lines and product families across national networks. Bakery protease demand in the USA is forecast to expand at 8.1% CAGR through 2036 tied to recurring flour-standardization work, while rollout becomes harder if dose response changes between flour sources or process conditions. Bureau of Labor Statistics data published in December 2025 recorded 268.8 thousand employees in bread and bakery product manufacturing during November, giving enzyme companies a broad industrial account base that rewards repeatable trial protocols and responsive technical service.

Who are the notable companies in the Bakery Proteases Market?

Novonesis, IFF, Kerry Group, AB Enzymes, Puratos, Corbion, dsm-firmenich, and Lallemand are the notable companies profiled in this market.

Industrial bakeries often qualify proteases inside broader flour improver programs because the dose decision must fit the same flour and line conditions as other dough conditioners. Diversified industrial enzyme groups therefore need bakery application teams that can turn enzyme activity into a stable customer specification.

• Novonesis, IFF and Kerry Group bring broad food-enzyme portfolios with dedicated bakery application resources and global customer coverage.
• AB Enzymes and Lallemand emphasize fermentation-derived enzyme expertise with direct baking support for formulators, millers and industrial bakery programs.
• Puratos, Corbion and dsm-firmenich use wider bakery formulation platforms that link enzymes with texture and flour-performance work.

Kerry and IFF also support fine-bakery programs, giving their cake enzyme teams experience with batter systems that require different texture and process targets from bread dough.

Competitive Benchmarking: Bakery Proteases Market

Company	Bakery Enzyme Portfolio Depth	Plant-Scale Application Support	Reformulation & Specialty Support	Geographic Reach
Novonesis	High	High	High	Global
IFF	High	High	High	Global
Kerry Group	High	High	High	Global
AB Enzymes	High	High	Medium	Global with regional baking labs
Puratos	Medium	High	High	Global bakery network
Corbion	Medium	High	High	Global food customer base
dsm-firmenich	Medium	High	High	Global
Lallemand	Medium	High	High	Global bakery network

Scoring basis: High portfolio depth requires multiple documented bakery-enzyme routes while Medium requires narrower evidence and Low identifies one documented route. High application support requires dedicated bakery trial infrastructure or repeated plant-scale evidence that reaches production conditions. Medium denotes documented application support without dedicated baking facilities, while Low identifies indirect or limited support. High reformulation support requires several documented bakery formulation routes, while Medium requires two routes and Low identifies one.

Key Developments in the Bakery Proteases Market

• In June 2026, AB Enzymes opened a new office and baking lab in Curitiba to run hands-on trials and provide closer application support for South American customers.
• In June 2025, Lallemand completed the acquisition of AIT Ingredients to expand its baking-solutions portfolio and application knowledge for bakery and flour-milling customers.
• In June 2026, Puratos opened a Flour Competence Center in Belgium to link flour analysis with bakery application guidance and improve response to flour variability.

Key Players in the Bakery Proteases Market

Global Bakery Enzyme Platforms

• Novonesis
• IFF
• Kerry Group
• dsm-firmenich

Enzyme and Baking Specialists

• AB Enzymes
• Lallemand

Bakery Formulation Platforms

• Puratos
• Corbion

Bakery Proteases Market - Report Scope

Coverage field	Report scope
Market breakdown	By product type, form, application, claim, sales channel and region.
Quantitative Units	USD million.
Market Definition	Commercial bakery protease products used to modify dough or flour performance within the defined bakery application and sales-channel boundary.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, and Middle East and Africa.
Countries Covered	UAE, Saudi Arabia, South Korea, UK, USA, and 20+ countries included in the full report.
Key Companies Profiled	Novonesis, IFF, Kerry Group, AB Enzymes, Puratos, Corbion, dsm-firmenich, and Lallemand.
Forecast Period	2026 to 2036.
Approach	Primary and secondary research with market triangulation.

Bakery Proteases Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Bakery Proteases Market by Segments

Bakery Proteases Market segmented by Product Type:

• Standard grade
• Premium / specialty grade
• Organic certified
• Clean label grade

Bakery Proteases Market segmented by Form:

• Powder - dry
• Liquid
• Paste / semi-solid
• Granules / pieces

Bakery Proteases Market segmented by Application:

• Bread & rolls
• Cakes & muffins
• Biscuits & cookies
• Viennoiserie & pastry
• Other bakery & snacks

Bakery Proteases Market segmented by Claim:

• Conventional
• Clean label
• Organic
• Non-GMO / identity preserved

Bakery Proteases Market segmented by Sales Channel:

• Direct to industrial bakeries
• Ingredient distributors
• Foodservice & artisan supply
• Online B2B

Bakery Proteases Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • France
  • Nordics
  • Benelux
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan and Baltic States
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
  • Rest of South Asia and Pacific
• Middle East and Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Türkiye
  • South Africa
  • Other African Union Countries
  • Rest of Middle East and Africa

Research Sources and Bibliography

• USA Department of Agriculture, National Agricultural Statistics Service. (2025, August 1). Flour Milling Products.
• Department for Environment, Food & Rural Affairs. (2026, July 29). Food statistics in your pocket.
• USA Food and Drug Administration. (2025, March 14). GRN No. 1197: Fructanase enzyme preparation.
• USA Food and Drug Administration. (2025, March 3). GRN No. 1196: Triacylglycerol lipase enzyme preparation.
• IFF. (2025, August 13). IFF Launches POWERFRESH® ACE 2000, a Bread Fresh-Keeping Solution That “Aces” the Shelf-Life Test.
• USA Food and Drug Administration. (2026, April 8). GRN No. 1276: Cellulase enzyme preparation.
• USA Department of Agriculture, Economic Research Service. (2026, April 8). Wheat Sector at a Glance.
• UK Government. (2026, July 3). Reforms to the market authorisations process for regulated products.
• dsm-firmenich. (2025, May 20). On the rise: dsm-firmenich opens state-of-the-art Princeton Baking Innovation Center in Princeton, NJ.
• UAE Cabinet. (2026, April 26). Mohammed bin Rashid approves decisions to enhance industrial resilience, support national products.
• Saudi Food and Drug Authority. (2025, May 10). The SFDA Implements Expanded Inspection Campaigns on Food Factories Ahead of Hajj Season.
• Ministry of Food and Drug Safety, Republic of Korea. (2025, March 18). Food Additives Code incorporating Notice No. 2025-15.
• Office for National Statistics. (2025, November 13). 10.7:Manufacture of Bakery and Farinaceous Products: CVM: annual & monthly gr.
• USA Bureau of Labor Statistics. (2025, December). Table B-1a. Employees on nonfarm payrolls by industry sector and selected industry detail.
• Novonesis. (2025, January 2). The bromate era has faded. Here’s how to make your baked goods healthier and more sustainable.
• AB Enzymes. (2026, June 1). AB Enzymes Opens New Office and Baking Lab in Curitiba, Brazil.
• Lallemand. (2025, July 4). Lallemand Acquires AIT Ingredients.
• Puratos. (2026, June 15). Puratos opens new research center to tackle flour variability.
• Kerry. (2026, March 19). Kerry publishes 2025 Annual Report: A year defined by impact, innovation and purpose.
• Puratos. (2025, May 7). Puratos brings a trio of transformative innovations to iba 2025.
• Corbion. (2025, November 20). Capital Markets Day 2025.
• dsm-firmenich. (2025, October 2). dsm-firmenich opens global food innovation center in Delft, the Netherlands to accelerate diet transformation.
• Kerry. (2026, February 11). Kerry inaugurates its Customer Co-Creation Center in Medellín and boosts Collaborative Innovation in the Andean Region.
• AB Enzymes. (2026, May 12). AB Enzymes Strengthens Presence in Mexico, Central America & the Caribbean.
• International Flavors & Fragrances Inc. (2026, February 27). Annual report on Form 10-K for the year ended December 31, 2025.
• Lallemand. (2025, July 17). Lallemand acquires enzyme specialist Solyve.
• Novonesis. (2025, June 11). Novonesis launches Optiva® LS Prime, helping bakers cut up to 50% added sugar and create more cost-effective baked goods.
• Puratos. (2025, August 25). Puratos Announces Two New Hubs for Food Innovation: Montreal and Costa Rica.
• Corbion. (2026, June 15). Corbion launches LUMI™ Set to help bakers reformulate away from titanium dioxide without sacrificing visual appeal.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations

This Report Answers

• How large is the bakery proteases market in 2026 and what value is forecast by 2036?
• Which operating problems cause industrial bakers to qualify proteases for dough and flour control?
• Why does standard grade account for 45.0% of product type demand in 2026?
• Why does powder - dry hold 43.0% of form demand during the 2026 base year?
• Why do bread & rolls represent 34.0% of application demand in 2026?
• How do the five profiled country CAGRs differ from UAE through USA?
• Which qualification issues can delay a bakery protease from plant trial to regular specification?
• Which companies are benchmarked for bakery enzyme and application capability?
• How should industrial bakeries compare protease offers beyond enzyme price and activity units?